Da: Revaluation Books, Exeter, Regno Unito
EUR 162,24
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 320 pages. 9.25x7.50x9.25 inches. In Stock.
Da: Majestic Books, Hounslow, Regno Unito
EUR 170,19
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 191,34
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 153,05
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Lingua: Inglese
Editore: Elsevier Science Publishing Co Inc, San Diego, 2026
ISBN 10: 0443457174 ISBN 13: 9780443457173
Da: CitiRetail, Stevenage, Regno Unito
EUR 171,98
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: new. Paperback. Novel and Innovative Drug Delivery Systems to Overcome Chemoresistance in Human Malignancies addresses the critical challenge of cancer chemoresistance, synthesizing insights from cancer biology, molecular biology, biotechnology, and nanotechnology. The book explores the complex mechanisms underlying drug resistance, including alterations in key signaling pathways and the tumor microenvironment's role in cancer cell survival. It highlights advancements in drug delivery technologies, such as nanomedicine and biomimetic strategies, which enhance drug targeting and minimize off-target effects. The integration of techniques like CRISPR-Cas9 and artificial intelligence in developing next-generation therapies is also emphasized.For an academic audience, this book serves as an essential resource to foster interdisciplinary collaboration in cancer research. It equips researchers, clinicians, and industry professionals with the knowledge needed to navigate the evolving landscape of cancer therapeutics, addressing critical challenges in drug delivery and chemoresistance to improve patient outcomes. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.